Role of phytobiotics in relieving the impacts of Aeromonas hydrophila infection on aquatic animals: A mini-review

Front Vet Sci. 2022 Oct 6:9:1023784. doi: 10.3389/fvets.2022.1023784. eCollection 2022.

Abstract

Aeromonas hydrophila is a ubiquitous bacterium with various hosts that causes mass mortality in farm-raised fish species and significant economic losses. The current antibiotic treatment is ineffective in controlling this bacterium infection in aquaculture species. Therefore, an evaluation of potential phytobiotics is needed to find an alternative antimicrobial agent to reduce the over-reliance on antibiotics in aquaculture and safeguard public and environmental health. Furthermore, the rise in antibiotic resistance cases among pathogenic bacteria indicates an urgent need for new fish and shellfish health management solutions. In this context, phytobiotics applications in aquaculture can be defined as any medicinal plant-based antimicrobial agent used in fish and shellfish health management. This review will focus on the impacts of Motile Aeromonas Septicemia (MAS) due to A. hydrophila in aquaculture, the potential of phytobiotics in enhancing the tolerance of aquaculture species against MAS and the combination of phytobiotics with other antimicrobial and therapeutic agents against MAS.

Keywords: anti-bacterial activity; disease resistance; innate immunity; motile aeromonad septicemia (MAS); plant extract; synergistic.

Publication types

  • Review